Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Eribulin Mesylate Injection is indicated for the treatment of adults with metastatic breast cancer who have previously undergone at least two chemotherapy regimens for metastatic disease. It is also used for the treatment of patients with unresectable or metastatic liposarcoma who have received a prior anthracycline-containing regimen.
According to IQVIA MAT data for April 2026, the reference drug Halaven recorded estimated annual sales of approximately $43.7 million in the United States.
NATCO Pharma, headquartered in Hyderabad, India, develops, manufactures and distributes generic and branded pharmaceuticals, specialty pharmaceuticals, active pharmaceutical ingredients and crop protection products. The company reported a 34.11% year-on-year decline in consolidated net profit to Rs 267.9 crore in Q4 FY26, compared with Rs 406.6 crore posted in the corresponding quarter last year. Revenue from operations fell 39.46% YoY to Rs 739.1 crore in the quarter ended 31 March 2026. The counter slipped 2.48% to Rs 915.80 on the BSE.
Lupin is a global pharmaceutical company focused on branded and generic formulations, complex generics, biotechnology products and active pharmaceutical ingredients across multiple therapeutic segments. The company’s consolidated profit after tax stood at Rs 1,468.70 crore in Q4 FY26, up 87.72% from Rs 782.40 crore in Q4 FY25 and higher by 24.42% from Rs 1,180.50 crore in Q3 FY26. Net sales rose 32.9% to Rs 7391.91 crore in Q4 FY26 from Rs 5562.2 crore in Q4 FY25. It increased 4.1% sequentially from Rs 7100.5 crore in Q3 FY26. The counter shed 0.20% to Rs 2,245.10 on the BSE.
Lupin and its alliance partner Natco Pharma (Natco) today announced the approval from the United States Food and Drug Administration (U.S. FDA) for Natco's Abbreviated New Drug Application (ANDA) for Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) Single-Dose Vials.
Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) Single-Dose Vials is the bioequivalent to the reference listed drug (RLD) Halaven® Injection of Eisai, Inc.
Eribulin Mesylate Injection is indicated for the treatment of adults with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic disease and unresectable or metastatic liposarcoma who have received a prior anthracycline-containing regimen.
For the full year,net profit declined 24.76% to Rs 1418.50 crore in the year ended March 2026 as against Rs 1885.40 crore during the previous year ended March 2025. Sales declined 7.93% to Rs 4078.30 crore in the year ended March 2026 as against Rs 4429.50 crore during the previous year ended March 2025.
Profit before tax (PBT) declined sharply by 71.51% to Rs 144.1 crore in Q4 FY26 from Rs 505.9 crore recorded in Q4 FY25.
On the segmental front, revenue from the pharmaceuticals business stood at Rs 716.5 crore, down 40.58% year-on-year. Meanwhile, revenue from the agro chemicals segment increased 50.66% YoY to Rs 716.5 crore in Q4 FY26.
For the full financial year FY26, Natco Pharma reported a 24.76% decline in consolidated net profit to Rs 1,418.5 crore. Revenue from operations decreased 7.92% year-on-year to Rs 4,078.3 crore in FY26.
NATCO Pharma, headquartered at Hyderabad, India, develops, manufactures and distributes generic and branded pharmaceuticals, specialty pharmaceuticals, active pharmaceutical ingredients and crop protection products.
Delta Corp Ltd, ISGEC Heavy Engineering Ltd, Jyoti CNC Automation Ltd and Bharat Dynamics Ltd are among the other losers in the BSE's 'A' group today, 29 May 2026.
Natco Pharma Ltd tumbled 10.70% to Rs 1049.8 at 14:46 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 1.18 lakh shares were traded on the counter so far as against the average daily volumes of 53556 shares in the past one month.
Delta Corp Ltd lost 8.62% to Rs 74.01. The stock was the second biggest loser in 'A' group.On the BSE, 26.91 lakh shares were traded on the counter so far as against the average daily volumes of 2.64 lakh shares in the past one month.
ISGEC Heavy Engineering Ltd crashed 8.55% to Rs 944.4. The stock was the third biggest loser in 'A' group.On the BSE, 10635 shares were traded on the counter so far as against the average daily volumes of 3711 shares in the past one month.
Jyoti CNC Automation Ltd dropped 8.06% to Rs 604. The stock was the fourth biggest loser in 'A' group.On the BSE, 5.14 lakh shares were traded on the counter so far as against the average daily volumes of 70030 shares in the past one month.
Bharat Dynamics Ltd fell 7.90% to Rs 1182. The stock was the fifth biggest loser in 'A' group.On the BSE, 5.14 lakh shares were traded on the counter so far as against the average daily volumes of 89799 shares in the past one month.
Shares of Sammaan Capital are banned from F&O trading on Wednesday 04 March 2026.
Stocks to Watch:
Oil sensitive stocks will continue to remain as tensions in West Asia persist.
Adani Ports & Special Economic Zone (APSEZ) handled 42.5 MT in February 2026, registering the growth of 16% YoY. Logistics rail volume stood at 52,101 TEUs in February 2026, up 3% YoY.
Natco Pharma along with its partner Breckenridge Pharmaceutical, Inc announces launch of Pomalidomide Capsules. The said drug is indicated for the treatment of adult patients with multiple myeloma who have received at least two prior therapies
Gland Pharma’s chief executive officer(CEO), Shyamakant Giri, has resigned from the position with effect from 30 April 2026.
Juniper Hotels has received letter of award (LoA) from Delhi Development Authority (DDA) to develop 5 star hotel property on licensed land parcel in Dwarka, New Delhi
Allied Blenders and Distillers' board approved to acquire upto 50% stake in Kion Blenders Industries for total consideration of Rs 45 crore.
JSW Cement has been declared as the preferred bidder for the mining lease of the Sikilangso Limestone Block (Part A & Part B) located in Umrangso, Dima Hasao District, Assam.
The drug is also approved for AIDS-related Kaposi sarcoma after failure of highly active antiretroviral therapy (HAART), as well as for HIV-negative adult patients with Kaposi sarcoma. The product is available in 1 mg, 2 mg, 3 mg, and 4 mg strengths and is primarily distributed through specialty pharmacies and clinics.
NATCO said based on information made available by the U.S. Food and Drug Administration (FDA), it believes that it has 180 days of shared exclusivity. Pomalidomide Capsules 1 mg, 2 mg, 3 mg, and 4 mg had estimated sales of $3.2 billion in the U.S. for the 12 months ending September 2025, the company said, citing industry sales data.
Rajeev Nannapaneni, vice chairman and chief executive officer of NATCO Pharma, said, “We are pleased to launch Pomalidomide Capsules in the U.S.; this further strengthens our oncology and specialty portfolio in the U.S. The launch highlights our commitment to our mission of making specialty medicines accessible to all the patients worldwide. We look forward to bringing more such complex and specialty products to the market in the coming years.”
NATCO Pharma, headquartered in Hyderabad, India, develops, manufactures, and distributes generic and branded pharmaceuticals, specialty pharmaceuticals, active pharmaceutical ingredients, and crop protection products.
The company’s consolidated net profit jumped 13.9% to Rs 151.50 crore on a 36.3% increase in revenue from operations to Rs 647.30 crore in Q3 FY26 over Q3 FY25.
Fine Organic Industries Ltd, Natco Pharma Ltd, Apollo Micro Systems Ltd and Jammu and Kashmir Bank Ltd are among the other gainers in the BSE's 'A' group today, 24 February 2026.
Thangamayil Jewellery Ltd spiked 4.92% to Rs 3771.5 at 11:45 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 12753 shares were traded on the counter so far as against the average daily volumes of 9643 shares in the past one month.
Fine Organic Industries Ltd soared 4.66% to Rs 4862.5. The stock was the second biggest gainer in 'A' group. On the BSE, 7484 shares were traded on the counter so far as against the average daily volumes of 941 shares in the past one month.
Natco Pharma Ltd surged 4.63% to Rs 934.55. The stock was the third biggest gainer in 'A' group. On the BSE, 6.43 lakh shares were traded on the counter so far as against the average daily volumes of 1.53 lakh shares in the past one month.
Apollo Micro Systems Ltd added 4.34% to Rs 240.55. The stock was the fourth biggest gainer in 'A' group. On the BSE, 1.86 lakh shares were traded on the counter so far as against the average daily volumes of 1.59 lakh shares in the past one month.
Jammu and Kashmir Bank Ltd jumped 4.18% to Rs 110.9. The stock was the fifth biggest gainer in 'A' group. On the BSE, 12.05 lakh shares were traded on the counter so far as against the average daily volumes of 2.05 lakh shares in the past one month.
Natco Pharma Ltd, Cartrade Tech Ltd, KFin Technologies Ltd and Engineers India Ltd are among the other gainers in the BSE's 'A' group today, 16 February 2026.
Easy Trip Planners Ltd soared 11.95% to Rs 7.4 at 11:46 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 34.75 lakh shares were traded on the counter so far as against the average daily volumes of 11.75 lakh shares in the past one month.
Natco Pharma Ltd surged 8.70% to Rs 893.65. The stock was the second biggest gainer in 'A' group. On the BSE, 12.11 lakh shares were traded on the counter so far as against the average daily volumes of 40895 shares in the past one month.
Cartrade Tech Ltd spiked 7.51% to Rs 2083.45. The stock was the third biggest gainer in 'A' group. On the BSE, 41903 shares were traded on the counter so far as against the average daily volumes of 31425 shares in the past one month.
KFin Technologies Ltd spurt 6.27% to Rs 1028.8. The stock was the fourth biggest gainer in 'A' group. On the BSE, 1.04 lakh shares were traded on the counter so far as against the average daily volumes of 35506 shares in the past one month.
Engineers India Ltd added 6.07% to Rs 214.1. The stock was the fifth biggest gainer in 'A' group. On the BSE, 30.9 lakh shares were traded on the counter so far as against the average daily volumes of 4.66 lakh shares in the past one month.